View Item 

Show simple item record

Macrophage migration inhibitory factor‐knockout mice are long lived and respond to caloric restriction
dc.contributor.authorHarper, James M.
dc.contributor.authorWilkinson, J. Erby
dc.contributor.authorMiller, Richard A.
dc.date.accessioned2020-04-02T18:40:25Z
dc.date.available2020-04-02T18:40:25Z
dc.date.issued2010-07
dc.identifier.citationHarper, James M.; Wilkinson, J. Erby; Miller, Richard A. (2010). "Macrophage migration inhibitory factor‐knockout mice are long lived and respond to caloric restriction." The FASEB Journal 24(7): 2436-2442.
dc.identifier.issn0892-6638
dc.identifier.issn1530-6860
dc.identifier.urihttps://hdl.handle.net/2027.42/154680
dc.publisherFederation of American Societies for Experimental Biology
dc.publisherWiley Periodicals, Inc.
dc.subject.othercancer
dc.subject.otherinflammation
dc.subject.otherlife span
dc.subject.otherCR
dc.subject.otherMIF
dc.titleMacrophage migration inhibitory factor‐knockout mice are long lived and respond to caloric restriction
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelBiology
dc.subject.hlbtoplevelScience
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/154680/1/fsb2fj09152223.pdf
dc.identifier.doi10.1096/fj.09-152223
dc.identifier.sourceThe FASEB Journal
dc.identifier.citedreferenceHonda, A., Abe, R., Yoshihisa, Y., Makino, T., Matsunaga, K., Nishihira, J., Shimizu, H., and Shimizu, T. ( 2009 ) Deficient deletion of apoptotic cells by macrophage migration inhibitory factor (MIF) overexpression accelerates photocarcinogenesis. Carcinogenesis 30, 1597 – 1605
dc.identifier.citedreferenceRadstake, T. R., Sweep, F. C., Welsing, P., Franke, B., Vermeulen, S. H., Geurts‐Moespot, A., Calandra, T., Donn, R., and van Riel, P. L. ( 2005 ) Correlation of rheumatoid arthritis severity with the genetic functional variants and circulating levels of macrophage migration inhibitory factor. Arthritis Rheum. 52, 3020 – 3029
dc.identifier.citedreferenceAwandare, G. A., Martinson, J. J., Were, T., Ouma, C., Davenport, G. C., Ong’echa, J. M., Wang, W., Leng, L., Ferrell, R. E., Bucala, R., and Perkins, D. J. ( 2009 ) MIF (macrophage migration inhibitory factor) promoter polymorphisms and susceptibility to severe malarial anemia. J. Infect. Dis. 200, 629 – 637
dc.identifier.citedreferenceDenz, A., Pilarsky, C., Muth, D., Rückert, F., Saeger, H.‐D., and Grützmann, R. ( 2010 ) Inhibition of MIF leads to cell cycle arrest and apoptosis in pancreatic cancer cells. J. Surg. Res. 151, 298 – 298
dc.identifier.citedreferenceHarry Hua‐Xiang, X., Yi, Y., Kent‐Man, C., Qing, G., Yuan‐Yuan, Z., Hua, H., Wai Man, W., Suet‐Yi, L., Siu‐Tsan, Y., Man‐Fung, Y., Annie, O. O. C., and Benjamin, C. Y. W. ( 2009 ) Serum macrophage migration‐inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer. Cancer 115, 5441 – 5449
dc.identifier.citedreferenceXu, X., Wang, B., Ye, C., Yao, C., Lin, Y., Huang, X., Zhang, Y., and Wang, S. ( 2008 ) Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett. 261, 147 – 157
dc.identifier.citedreferenceTaylor, J., Kuchel, G., Hegde, P., Voznesensky, O., Claffey, K., Tsimikas, J., Leng, L., Bucala, R., and Pilbeam, C. ( 2007 ) Null mutation for macrophage migration inhibitory factor (MIF) is associated with less aggressive bladder cancer in mice. BMC Cancer 7, 135
dc.identifier.citedreferenceWilson, J. M., Coletta, P. L., Cuthbert, R. J., Scott, N., MacLennan, K., Hawcroft, G., Leng, L., Lubetsky, J. B., Jin, K. K., Lolis, E., Medina, F., Brieva, J. A., Poulsom, R., Markham, A. F., Bucala, R., and Hull, M. A. ( 2005 ) Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology 129, 1485 – 1503
dc.identifier.citedreferenceDing, G. X., Zhou, S. Q., Xu, Z., Feng, N. H., Song, N. H., Wang, X. J., Yang, J., Zhang, W., Wu, H. F., and Hua, L. X. ( 2009 ) The association between MIF‐173 GC polymorphism and prostate cancer in southern Chinese. J. Surg. Oncol. 100, 106 – 110
dc.identifier.citedreferenceHagemann, T., Robinson, S. C., Thompson, R. G., Charles, K., Kulbe, H., and Balkwill, F. R. ( 2007 ) Ovarian cancer cell‐derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis. Mol. Cancer Therapeutics 6, 1993 – 2002
dc.identifier.citedreferenceKoska, J., Stefan, N., Dubois, S., Trinidad, C., Considine, R. V., Funahashi, T., Bunt, J. C., Ravussin, E., and Permana, P. A. ( 2009 ) mRNA concentrations of MIF in subcutaneous abdominal adipose cells are associated with adipocyte size and insulin action. Int. J. Obes. 33, 842 – 850
dc.identifier.citedreferenceHerder, C., Klopp, N., Baumert, J., Müller, M., Khuseyinova, N., Meisinger, C., Martin, S., Illig, T., Koenig, W., and Thorand, B. ( 2008 ) Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case–Cohort Study, 1984–2002. Diabetologia 51, 276 – 284
dc.identifier.citedreferenceStosic‐Grujicic, S., Stojanovic, I., Maksimovic‐Ivanic, D., Momcilovic, M., Popadic, D., Harhaji, L., Miljkovic, D., Metz, C., Mangano, K., Papaccio, G., Al‐Abed, Y., and Nicoletti, F. ( 2008 ) Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus. J. Cell. Physiol. 215, 665 – 675
dc.identifier.citedreferenceVerschuren, L., Kooistra, T., Bernhagen, J., Voshol, P. J., Ouwens, D. M., van Erk, M., de Vries‐van der Weij, J., Leng, L., van Bockel, J. H., van Dijk, K. W., Fingerle‐Rowson, G., Bucala, R., and Kleemann, R. ( 2009 ) MIF deficiency reduces chronic inflammation in white adipose tissue and impairs the development of insulin resistance, glucose intolerance, and associated atherosclerotic disease. Circ. Res. 105, 99 – 107
dc.identifier.citedreferenceYabunaka, N., Nishihira, J., Mizue, Y., Tsuji, M., Kumagai, M., Ohtsuka, Y., Imamura, M., and Asaka, M. ( 2000 ) Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes. Diabetes Care 23, 256 – 258
dc.identifier.citedreferenceHerder, C., Kolb, H., Koenig, W., Haastert, B., Müller‐Scholze, S., Rathmann, W., Holle, R., Thorand, B., and Wichmann, H. E. ( 2006 ) Association of systemic concentrations of macrophage migration inhibitory factor with impaired glucose tolerance and type 2 diabetes. Diabetes Care 29, 368 – 371
dc.identifier.citedreferenceThorand, B., Baumert, J., Kolb, H., Meisinger, C., Chambless, L., Koenig, W., and Herder, C. ( 2007 ) Sex differences in the prediction of type 2 diabetes by inflammatory markers. Diabetes Care 30, 854 – 860
dc.identifier.citedreferenceBocheva, A., Dzambazova, E., Hadjiolova, R., Traikov, L., Mincheva, R., and Bivolarski, I. ( 2008 ) Effect of Tyr‐MIF‐1 peptides on blood ACTH and corticosterone concentration induced by three experimental models of stress. Auton. Autacoid. Pharmacol. 28, 117 – 123
dc.identifier.citedreferenceFingerle‐Rowson, G., Koch, P., Bikoff, R., Lin, X., Metz, C. N., Dhabhar, F. S., Meinhardt, A., and Bucala, R. ( 2003 ) Regulation of macrophage migration inhibitory factor expression by glucocorticoids in vivo. Am. J. Pathol. 162, 47 – 56
dc.identifier.citedreferenceCavigelli, S. A., and McClintock, M. K. ( 2003 ) Fear of novelty in infant rats predicts adult corticosterone dynamics and an early death. Proc. Natl. Acad. Sci. USA 100, 16131 – 16136
dc.identifier.citedreferenceCavigelli, S. A., Yee, J. R., and McClintock, M. K. ( 2006 ) Infant temperament predicts life span in female rats that develop spontaneous tumors. Horm. Behav. 50, 454 – 462
dc.identifier.citedreferenceYee, J. R., Cavigelli, S. A., Delgado, B., and McClintock, M. K. ( 2008 ) Reciprocal affiliation among adolescent rats during a mild group stressor predicts mammary tumors and lifespan. Psychosom. Med. 70, 1050 – 1059
dc.identifier.citedreferenceBucala, R. ( 1996 ) MIF rediscovered: cytokine, pituitary hormone, and glucocorticoid‐induced regulator of the immune response. FASEB J. 10, 1607 – 1613
dc.identifier.citedreferenceBacher, M., Meinhardt, A., Lan, H., Mu, W., Metz, C., Chesney, J., Calandra, T., Gemsa, D., Donelly, T., Atkins, R., and Bucala, R. ( 1997 ) Migration inhibitory factor expression in experimentally induced endotoxemia. Am. J. Pathol. 150, 12
dc.identifier.citedreferenceCalandra, T., Bernhagen, J., Mitchell, R., and Bucala, R. ( 1994 ) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 179, 8
dc.identifier.citedreferenceFingerle‐Rowson, G. R., and Bucala, R. ( 2001 ) Neuroendocrine properties of macrophage migration inhibitory factor (MIF). Immunol. Cell Biol. 79, 368 – 375
dc.identifier.citedreferenceCvetkovic, I., and Stosic‐Grujicic, S. ( 2006 ) Neutralization of macrophage migration inhibitory factor—novel approach for the treatment of immunoinflammatory disorders. Int. Immunopharmacol. 6, 1527 – 1534
dc.identifier.citedreferenceToso, C., Emamaullee, J., Merani, S., and Shapiro, A. ( 2008 ) The role of macrophage migration inhibitory factor on glucose metabolism and diabetes. Diabetologia 51, 1937 – 1946
dc.identifier.citedreferenceFingerle‐Rowson, G., and Petrenko, O. ( 2007 ) MIF coordinates the cell cycle with DNA damage checkpoints. Lessons from knockout mouse models. Cell Div. 2, 22
dc.identifier.citedreferenceRendon, B. E., Willer, S. S., Zundel, W., and Mitchell, R. A. ( 2009 ) Mechanisms of macrophage migration inhibitory factor (MIF)‐dependent tumor microenvironmental adaptation. Exp. Mol. Pathol. 86, 180 – 185
dc.identifier.citedreferenceNemajerova, A., Mena, P., Fingerle‐Rowson, G., Moll, U. M., and Petrenko, O. ( 2007 ) Impaired DNA damage checkpoint response in MIF‐deficient mice. EMBO J. 26, 987 – 997
dc.identifier.citedreferenceBach, J.‐P., Deuster, O., Balzer‐Geldsetzer, M., Meyer, B., Dodel, R., and Bacher, M. ( 2009 ) The role of macrophage inhibitory factor in tumorigenesis and central nervous system tumors. Cancer 115, 2031 – 2040
dc.identifier.citedreferenceMeyer‐Siegler, K. L., Iczkowski, K. A., Leng, L., Bucala, R., and Vera, P. L. ( 2006 ) Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU‐145 prostate cancer cells. J. Immunol. 177, 8730 – 8739
dc.identifier.citedreferenceWinner, M., Meier, J., Zierow, S., Rendon, B. E., Crichlow, G. V., Riggs, R., Bucala, R., Leng, L., Smith, N., Lolis, E., Trent, J. O., and Mitchell, R. A. ( 2008 ) A novel, macrophage migration inhibitory factor suicide substrate inhibits motility and growth of lung cancer cells. Cancer Res. 68, 7253 – 7257
dc.identifier.citedreferenceMartin, J., Duncan, F. J., Keiser, T., Shin, S., Kusewitt, D. F., Oberyszyn, T., Satoskar, A. R., and VanBuskirk, A. M. ( 2009 ) Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet‐B (UVB) ‐induced nonmelanoma skin cancer (NMSC). FASEB J. 23, 720 – 730
dc.identifier.citedreferenceGanguly, R., Waldman, R., Craig, C., and Lockey, R. ( 1986 ) Effects of age on respiratory tract immunity in guinea pigs. Allergol. Immunopathol. (Madr.) 14, 1 – 7
dc.identifier.citedreferenceGanguly, R., and Lockey, R. ( 1985 ) Age interference of lymphokine production by lung derived lymphocytes. Allerg. Immunol. (Leipz.) 31, 203 – 206
dc.identifier.citedreferenceMizue, Y., Nishihira, J., Miyazaki, T., Fujiwara, S., Chida, M., Nakamura, K., Kikuchi, K., and Mukai, M. ( 2000 ) Quantitation of macrophage migration inhibitory factor (MIF) using the one‐step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int. J. Mol. Med. 5, 397 – 403
dc.identifier.citedreferenceHardman, M. J., Waite, A., Zeef, L., Burow, M., Nakayama, T., and Ashcroft, G. S. ( 2005 ) Macrophage migration inhibitory factor: a central regulator of wound healing. Am. J. Pathol. 167, 1561 – 1574
dc.identifier.citedreferenceWelford, S., Bedogni, B., Gradin, K., Poellinger, Powell, M., and Giaccia, A. ( 2006 ) HIF1a delays premature senescence through the activation of MIF. Genes Dev. 20, 3366 – 3371
dc.identifier.citedreferenceBell, E. L., Klimova, T. A., Eisenbart, J., Schumacker, P. T., and Chandel, N. S. ( 2007 ) Mitochondrial reactive oxygen species trigger hypoxia‐inducible factor‐dependent extension of the replicative life span during hypoxia. Mol. Cell. Biol. 27, 5737 – 5745
dc.identifier.citedreferenceZhang, Y., Shao, Z., Zhai, Z., Shen, C., and Powell‐Coffman, J. A. ( 2009 ) The HIF‐1 hypoxia‐inducible factor modulates lifespan in C. elegans. PLoS ONE 4, e6348
dc.identifier.citedreferenceMehta, R., Steinkraus, K. A., Sutphin, G. L., Ramos, F. J., Shamieh, L. S., Huh, A., Davis, C., Chandler‐Brown, D., and Kaeberlein, M. ( 2009 ) Proteasomal Regulation of the hypoxic response modulates aging in C. elegans. Science 324, 1196 – 1198
dc.identifier.citedreferenceMiller, R. A., Chang, Y., Galecki, A., Al‐Regaiey, K., Kopchick, J. J., and Bartke, A. ( 2002 ) Gene expression patterns in calorically restricted mice: partial overlap with long‐lived mutant mice. Mol. Endocrinol. 16, 2657 – 2666
dc.identifier.citedreferenceMiller, R. A., Buehner, G., Chang, Y., Harper, J. M., Sigler, R., and Smith‐Wheelock, M. ( 2005 ) Methionine‐deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF‐I and insulin levels, and increases hepatocyte MIF levels and stress resistance. Aging Cell 4, 119 – 125
dc.identifier.citedreferenceRohrbach, S., Teichert, S., Niemann, B., Franke, C., and Katschinski, D. ( 2008 ) Caloric restriction counteracts age‐dependent changes in prolyl‐4‐hydroxylase domain (PHD) 3 expression. Biogerontology 9, 169 – 176
dc.identifier.citedreferenceBozza, M., Satoskar, A. R., Lin, G., Lu, B., Humbles, A. A., Gerard, C., and David, J. R. ( 1999 ) Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189, 341 – 346
dc.identifier.citedreferenceSatoskar, A. R., Bozza, M., Rodriguez Sosa, M., Lin, G., and David, J. R. ( 2001 ) Migration‐inhibitory factor gene‐deficient mice are susceptible to cutaneous Leishmania major infection. Infect. Immun. 69, 906 – 911
dc.identifier.citedreferenceBartke, A., Wright, J. C., Mattison, J. A., Ingram, D. K., Miller, R. A., and Roth, G. S. ( 2001 ) Longevity: extending the lifespan of long‐lived mice. Nature 414, 412 – 412
dc.identifier.citedreferenceWeindruch, R., and Walford, R. L. ( 1988 ) The Retardation of Aging and Disease by Dietary Restriction, Charles C. Thomas, Springfield, IL, USA
dc.identifier.citedreferenceWang, C., Li, Q., Redden, D. T., Weindruch, R., and Allison, D. B. ( 2004 ) Statistical methods for testing effects on “maximum lifespan.” Mech. Ageing Dev. 125, 629 – 632
dc.identifier.citedreferenceHonma, N., Koseki, H., Akasaka, T., Nakayama, T., Taniguchi, M., Serizawa, I., Akahori, H., Osawa, M., and Mikayama, T. ( 2000 ) Deficiency of the macrophage migration inhibitory factor gene has no significant effect on endotoxaemia. Immunology 100, 84 – 90
dc.identifier.citedreferenceAnahara, R., Toyama, Y., Koda, M., Honma, S., Nishihira, J., Toshimori, K., and Mori, C. ( 2006 ) Deletion of macrophage migration inhibitory factor gene induces down regulation of sex hormones and ultrastructural abnormalities in mouse testes. Reprod. Toxicol. 21, 167 – 170
dc.identifier.citedreferenceHogenEsch, H., Niewold, T., Higuchi, K., Tooten, P., Gruys, E., and Radl, J. ( 1993 ) Gastrointestinal AAPOAII and systemic AA‐amyloidosis in aged C57BL/Ka mice. Virchows Arch. B Cell Pathol. 64, 37 – 43
dc.identifier.citedreferenceFlaster, H., Bernhagen, J., Calandra, T., and Bucala, R. ( 2007 ) The macrophage migration inhibitory factor‐glucocorticoid dyad: regulation of inflammation and immunity. Mol. Endocrinol. 21, 1267 – 1280
dc.identifier.citedreferenceTurturro, A., Duffy, P., Hass, B., Kodell, R., and Hart, R. ( 2002 ) Survival characteristics and age‐adjusted disease incidences in C57BL/6 mice fed a commonly used cereal‐based diet modulated by dietary restriction. J. Gerontol. A. Biol. Sci. Med. Sci. 57, B379 – B389
dc.identifier.citedreferenceBach, J. P., Rinn, B., Meyer, B., Dodel, R., and Bacher, M. ( 2008 ) Role of MIF in inflammation and tumorigenesis. Oncology 75, 127 – 133
dc.identifier.citedreferenceSimpson, E. M., Linder, C. C., Sargent, E. E., Davisson, M. T., Mobraaten, L. E., and Sharp, J. J. ( 1997 ) Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat. Genet. 16, 19 – 27
dc.identifier.citedreferencePaiva, C. N., Arras, R. H., Magalhaes, E. S., Alves, L. S., Lessa, L. P., Silva, M. H., Ejzemberg, R., Canetti, C., and Bozza, M. T. ( 2009 ) Migration inhibitory factor (MIF) released by macrophages upon recognition of immune complexes is critical to inflammation in Arthus reaction. J. Leukoc. Biol. 85, 855 – 861
dc.identifier.citedreferenceMagalhaes, E. S., Paiva, C. N., Souza, H. S. P., Pyrrho, A. S., Mourao‐Sa, D., Figueiredo, R. T., Vieira‐de‐Abreu, A., Dutra, H. S., Silveira, M. S., Gaspar‐Elsas, M. I. C., Xavier‐Elsas, P., Bozza, P. T., and Bozza, M. T. ( 2009 ) Macrophage migration inhibitory factor is critical to interleukin‐5‐driven eosinophilopoiesis and tissue eosinophilia triggered by Schistosoma mansoni infection. FASEB J. 23, 1262 – 1271
dc.identifier.citedreferenceStosic‐Grujicic, S., Stojanovic, I., and Nicoletti, F. ( 2009 ) MIF in autoimmunity and novel therapeutic approaches. Autoimmun. Rev. 8, 244 – 249
dc.identifier.citedreferenceMorand, E. F. ( 2005 ) New therapeutic target in inflammatory disease: macrophage migration inhibitory factor. Int. Med. J. 35, 419 – 426
dc.identifier.citedreferenceMorand, E. F., Leech, M., and Bernhagen, J. ( 2006 ) MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat. Rev. Drug Discov. 5, 399 – 411
dc.identifier.citedreferenceMasternak, M. M., Al‐Regaiey, K. A., Del Rosario Lim, M. M., Jimenez‐Ortega, V., Panici, J. A., Bonkowski, M. S., Kopchick, J. J., Wang, Z., and Bartke, A. ( 2006 ) Caloric restriction and growth hormone receptor knockout: effects on expression of genes involved in insulin action in the heart. Exp. Gerontol. 41, 417 – 429
dc.identifier.citedreferenceAl‐Regaiey, K. A., Masternak, M. M., Bonkowski, M. S., Panici, J. A., Kopchick, J. J., and Bartke, A. ( 2007 ) Effects of caloric restriction and growth hormone resistance on insulin‐related intermediates in the skeletal muscle. J. Gerontol. A Biol. Sci. Med. Sci. 62, 18 – 26
dc.identifier.citedreferenceMitchell, R. A. ( 2004 ) Mechanisms and effectors of MIF‐dependent promotion of tumourigenesis. Cell. Signal. 16, 13 – 19
dc.identifier.citedreferenceDe Jong, Y. P., Abadia‐Molina, A. C., Satoskar, A. R., Clarke, K., Rietdijk, S. T., Faubion, W. A., Mizoguchi, E., Metz, C. N., Sahli, M. A., Ten Hove, T., Keates, A. C., Lubetsky, J. B., Farrell, R. J., Michetti, P., Van Deventer, S. J., Lolis, E., David, J. R., Bhan, A. K., and Terhorst, C. ( 2001 ) Development of chronic colitis is dependent on the cytokine MIF. Nat. Immunol. 2, 1061 – 1066
dc.identifier.citedreferenceBurger‐Kentischer, A., Goebel, H., Seiler, R., Fraedrich, G., Schaefer, H. E., Dimmeler, S., Kleemann, R., Bernhagen, J., and Ihling, C. ( 2002 ) Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis. Circulation 105, 1561 – 1566
dc.identifier.citedreferenceYoshitaka, S., Atsushi, M., Akihiko, S., Jun, N., Tetsuya, Y., and Tooru, S. ( 2003 ) Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. Gastroenterology 124, 725 – 736
dc.identifier.citedreferenceOhkawara, T., Mitsuyama, K., Takeda, H., Asaka, M., Fujiyama, Y., and Nishihira, J. ( 2008 ) Lack of macrophage migration inhibitory factor suppresses innate immune response in murine dextran sulfate sodium‐induced colitis. Scand. J. Gastroenterol. 43, 1497 – 1504
dc.identifier.citedreferencePan, J. H., Sukhova, G. K., Yang, J. T., Wang, B., Xie, T., Fu, H., Zhang, Y., Satoskar, A. R., David, J. R., Metz, C. N., Bucala, R., Fang, K., Simon, D. I., Chapman, H. A., Libby, P., and Shi, G. P. ( 2004 ) Macrophage migration inhibitory factor deficiency impairs atherosclerosis in low‐density lipoprotein receptor‐deficient mice. Circulation 109, 3149 – 3153
dc.identifier.citedreferenceRachelle, D., Zaynab, A., De Fabrizio, B., Cristina, M., Eleftheria, Z., Mark, L., Adam, S., Emma, S., Rebecca, L., William, E. R. O., Wendy, T., and David, R. ( 2002 ) Mutation screening of the macrophage migration inhibitory factor gene: Positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 46, 2402 – 2409
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
fsb2fj09152223.pdf
Size:
309.0KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.